A Long-term Follow-up Study in Participants Who Received CS-101

Recruiting now · Not applicable

Conditions studied: Beta-Thalassemia

In brief

This is a study to evaluate the long-term safety and efficacy of CS-101 in participants who received CS-101 in study CS -101-03 (NCT06065189)

Key facts

Study ID

NCT06479616

Run by

Children's Hospital of Fudan University

People needed

5

Starts

2024-06-18

Expected to finish

2027-06-01

Last updated by the study team

2025-09-10

Who can join

Age: 3 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants (or his or her legally appointed and authorized representative or guardian) must sign and date informed consent form (ICF) and, where applicable, an assent form
• Participants must have received CS-101 infusion in last IIT study

You may not qualify if…

• There are no exclusion criteria

Where it is running

• Children's Hospital of Fudan University — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.